RESOURCES

Blogs

Insight at the intersection of data science and real-world health

The Talking Room

Demystifying AI, LLMs and machine learning

Use Cases

How teams put the signals to work

Compliance Hub

Data integrity, ethical AI and regulatory standards

DrugVoice

Built to be defensible.

Compliance, ethics, and data integrity are part of the process.

TMLABS

About us

Where our proprietary models are trained, tested and refined

Articles & scientific publications

Peer-reviewed methodologies and validated outcomes

Latest paper

The New GLP-1 Consumer

Articles & Scientific Publications

DRUGVOICE

DrugVoice

Measure how your messaging lands and evidence what moved

SEE IT IN ACTION

Bring us a question you can’t answer.

We’ll show you what the conversation already contains, using your therapy area and your audience.

ABOUT US

About us

Where our proprietary models are trained, tested and refined

ESG

Responsible innovation and ethical data practice

WHO WE ARE

Data scientists who speak pharma.

A team built around one problem: making real-world conversation usable at scale.

AI in Pharma Marketing: Decoding Patient and HCP Conversations for Smarter Strategies
Grasping the trends, preferences, and lived experiences of both Patients and HCPs is crucial for developing impactful healthcare marketing strategies. Yet, navigating the complexity of unstructured data often poses significant challenges, particularly with the limitations of traditional manual methods. Studies reveal that 58% of marketers still rely on spreadsheets for marketing reports, and 65% manually transfer data into presentations. These outdated practices not only consume valuable time but are also prone to errors, delaying the ability to turn insights into action. Nearly half of marketing teams struggle to access a unified data source, compounding the challenge.

 

As data sources multiply and grow more complex, Strategists need advanced tools to simplify and accelerate the process of uncovering meaningful insights. AI solutions like Drug-GPT provide the capability to bridge this gap, offering streamlined analysis and actionable intelligence. By analyzing unstructured data from diverse sources—Patient surveys, HCP interviews, social media, community boards, and medical conference abstracts—Drug-GPT provides curated, actionable intelligence. This enables Strategists to gain a comprehensive view of the healthcare landscape and create campaigns that truly resonate whilst offering insights.

Bridging the Gap with AI through Drug-GPT 

Drug-GPT goes beyond the limitations of manual analysis, which often struggles to process unstructured data. It thrives on transforming raw conversational data from real-world patient and HCP interactions into actionable, curated intelligence. Through the curated analysis of Patient and HCP conversations, Drug-GPT enables Strategists to: 

1. Understand the Full Patient Journey 

Drug-GPT uses advanced multi-level sentiment and topic models to provide strategists with a 360-degree view. By analyzing conversational data, it allows strategists to gain a clear, comprehensive understanding of their audience through data visualizations, text summaries, and natural language insights. This enables them to identify key points and unmet needs in the Patient journey. With this AI-driven intelligence, Strategists can create more relevant marketing campaigns grounded in the lived experiences of Patients and enhance Patient engagement.

2. Measure Alignment Across Stakeholder Insights 

One of the key challenges for strategists is ensuring that their messaging resonates across both Patient and HCP audiences. Drug-GPT allows strategists to compare and analyze the alignment between insights from HCPs – based on real-world experiences. This AI-enhanced, dual-lens approach enables Strategists to assess how well their messaging speaks to both groups, both before and after launch, ensuring campaigns address the concerns and aspirations of both audiences. 

3. Capture Competitive Landscape Insights 

Drug-GPT structures data from a variety of sources—large or small—to provide actionable insights on the competitive landscape. By analyzing trends and patterns from conversations to event-based conversations around medical conferences. Drug-GPT can enable Strategists to shift priorities by quickly identifying emerging patterns. This ensures marketing strategies are informed not only by data source specific intelligence but also by external factors shaping the market from a variety of sources.  

 

Why It Matters: Shaping Your AI Plan for Impactful Healthcare Marketing

AI has moved beyond being a novelty; throughout 2024, it has proven its value in streamlining tactical tasks. But 2025 is poised to be the year AI becomes an indispensable strategic partner in healthcare marketing.

This shift presents a crucial opportunity to rethink how your strategy connects with both Patients and HCPs, ensuring your marketing efforts are better aligned, more impactful, and grounded in real-world conversational data. AI tools like Drug-GPT have moved beyond being optional; they are now essential for Strategists who want to gain deeper insights into both audiences while boosting productivity by up to 80% in 2025.

The tools are ready. The question is, are you?  Get in touch today to see how easy it is to integrate Drug-GPT in your 2025 AI plan. Book your call now.

Sign Up to Stay Ahead of Message Impact

Discover how Pharma marketeers are finally measuring which messages change HCP behavior. Our newsletter shares evidence-led insights powered by DrugVoice and the Message Resonance Score™ so you can predict and prove message impact—before prescriptions are written.

Subscribe on LinkedIn

Read More

#
$